Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2
about
Selecting for BRCA1 testing using a combination of homogeneous selection criteria and immunohistochemical characteristics of breast cancersMeta-analysis of BRCA1 and BRCA2 penetranceAnalysis of PALB2/FANCN-associated breast cancer familiesHistopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families.Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families.Recent Enhancements to the Genetic Risk Prediction Model BRCAPROClinical prediction rules in practice: review of clinical guidelines and survey of GPsWhy should primary care physicians know about breast cancer genetics?Population-Calibrated Gene Characterization: Estimating Age at Onset Distributions Associated With Cancer GenesClassification of Missense Mutations of Disease GenesCharacterization of BRCA1 and BRCA2 mutations in a large United States sampleA probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer familiesA prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group studyGenetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized MedicineThe meaning of malingering data: further applications of Bayes' theorem.Semiparametric Bayesian analysis of case-control data under conditional gene-environment independence.Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage.BayesMendel: an R environment for Mendelian risk predictionProspective screening study of 0.5 Tesla dedicated magnetic resonance imaging for the detection of breast cancer in young, high-risk women.Incorporating medical interventions into carrier probability estimation for genetic counseling.A family history of breast cancer will not predict female early onset breast cancer in a population-based settingSelecting a BRCA risk assessment model for use in a familial cancer clinic.A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example.Age of onset in familial breast cancer as background data for medical surveillanceReclassification of predictions for uncovering subgroup specific improvementGenetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers.Current strategies for the prevention of breast cancerAn assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain.Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability.Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 statusEfficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detectionBreast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population.Diffusion of breast cancer risk assessment in primary care.Clinical management of BRCA1- and BRCA2-associated breast cancer.Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions.Pathogenesis, prevention, diagnosis and treatment of breast cancer.Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models.
P2860
Q21260381-4E2C888A-8503-4EF6-819A-C3D109C8A704Q24654786-53B7DBA3-50E9-4111-9F24-358846138939Q24683771-54BA1195-BEF3-4A9E-8444-21CAF34D21D8Q24796660-9AA84F97-07BA-491D-B7C7-61732A130090Q24802704-0CDA732D-4067-4774-9BBB-D15A7BCFDA8EQ24810584-D8372502-BF6B-4716-9D67-8954339EF0CDQ26995389-1E84BC28-3C0D-4953-B90A-19E050422075Q27002373-3C961D9C-5F00-4B41-B715-D19937977053Q28383592-AC87B298-C85B-450A-A595-CCC61ADC641DQ28383948-6A48AA0E-E28D-4C17-ACCD-BA35539E8F15Q28383958-B7E4C3AB-17B0-4CF9-B86F-4780452A8A3DQ28383993-96107D4E-95EA-4023-9D92-BE7939601F69Q28384206-77D89FB9-FB65-481A-9AA1-7E9DBCE350DAQ30431721-8BE3DF6D-BD84-487F-865B-E6D114801168Q30513982-003DE174-C41A-444B-AEFE-218960E052EBQ30628241-00EB6DFF-13F4-4FBB-9FDE-D77E68417AFCQ31112039-0EF400CD-8153-419B-943C-13F3CDEDD575Q33221678-3A6DEA24-554B-4601-964B-B412052DD627Q33241509-B8E6FEA1-624F-455D-8F6F-877828BC497CQ33247995-4A2FDCE9-02DB-4FD8-988E-57DFB8885383Q33279688-1983CAD8-2AA1-4923-A315-C74057640EC1Q33354606-5AA9CFC2-AB7E-47FC-B7CC-0AE8DF9815EAQ33395135-9D03397F-5A1E-4524-BD0D-A921AA73102FQ33475933-FDC10B21-CCE2-4B51-86B7-07938F261D46Q33515727-A69F3B04-5816-486F-8C34-20B10D11631CQ33560893-BA13D3B3-8C66-40F9-943C-03D7ED0E9383Q33564013-0B1E4543-2275-4BFF-A738-7699CE8FC5E4Q33589900-F4F8B038-86B3-4DDD-BEAC-679B4FB51280Q33599463-94F82AB5-5C0F-466E-8137-699E226EC8F2Q33643562-D8BA3758-89D7-4485-A78C-E181C993860CQ33772896-61DFCD51-9AF5-414E-A335-F4ABCED224FBQ33783075-B8BDB758-BB5A-4572-A433-D8540CF51AC9Q33853726-E0D2784C-14B6-4E4C-B385-6597C98472FFQ33892384-838DAB98-015A-4DC0-A715-1A4FB4918355Q33902568-2EC0EF75-3850-4B4E-931B-1B31B6F15B30Q33915589-85C442CE-E121-4D6F-9248-FC5D271DBD21Q33947420-BD270A68-0AB0-45EA-A579-6E69EAA06B53Q34023647-154B3F5D-A646-4BF2-9052-F58C1F94EA94Q34049921-0410670E-4262-4ED2-8C4C-8EC8378E6753Q34102617-CC90DD76-B7EA-41C5-8E90-D6373C7EA636
P2860
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2
@ast
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2
@en
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2
@nl
type
label
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2
@ast
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2
@en
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2
@nl
prefLabel
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2
@ast
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2
@en
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2
@nl
P2093
P2860
P356
P1476
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2
@en
P2093
P2860
P304
P356
10.1086/301670
P407
P577
1998-01-01T00:00:00Z